Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2037093 | chr3:80574143 | T/A | 6.66E-5 | 177 | 19.53 | 24.03 | 27.2 | KM Plot |
PCPG | rs2037094 | chr3:80598101 | A/G | 7.96E-5 | 174 | 19.53 | 24.03 | 27.4 | KM Plot |
PCPG | rs2039744 | chr1:236896619 | C/T | 0.000321 | 174 | 24.85 | 25.53 | 10.3 | KM Plot |
PCPG | rs2046446 | chr6:123124386 | G/A | 3.53E-6 | 177 | 8.67 | 27.27 | 24.85 | KM Plot |
PCPG | rs2049778 | chr3:80598429 | T/G | 0.00013 | 176 | 19.87 | 24.53 | 27.4 | KM Plot |
PCPG | rs2062584 | chr3:193586088 | C/T | 0.000329 | 178 | 25.53 | 26.62 | 7.2 | KM Plot |
PCPG | rs2066807 | chr12:56740682 | C/G | 9.68E-8 | 177 | 25.17 | 29.13 | 9.98 | KM Plot |
PCPG | rs2066818 | chr12:56753822 | C/A | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs2066819 | chr12:56750204 | C/T | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs2074903 | chr16:89811663 | T/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2074904 | chr16:89811546 | A/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2074963 | chr16:89877269 | T/C | 0.000179 | 174 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs207906 | chr2:217012901 | A/G | 6.98E-5 | 175 | 2.93 | 25.17 | 25.4 | KM Plot |
PCPG | rs2097520 | chr1:9331973 | C/G | 1.73E-5 | 178 | 6.85 | 20.47 | 26.57 | KM Plot |
PCPG | rs2098029 | chr14:74427405 | C/T | 3.77E-6 | 176 | 25.4 | 29.7 | 10.3 | KM Plot |